Page last updated: 2024-12-06

schizandrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

schizandrin: a dibenzocyclooctadiene lignan; schizandra is the plant name [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3001664
CHEMBL ID253688
SCHEMBL ID568558
MeSH IDM0057146
PubMed CID468078
MeSH IDM0057146

Synonyms (54)

Synonym
dibenzo(a,c)cycloocten-6-ol, 5,6,7,8-tetrahydro-6,7-dimethyl-1,2 3,10,11,12-hexamethoxy-, stereoisomer
dibenzo(a,c)cycloocten-6-ol, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, stereoisomer
dibenzo[a,c]cycloocten-6-ol, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6s,7s)-
smr000445691
MLS000728484
CHEMBL253688
NCGC00247516-01
HMS2227F11
S3823
wuweizins
magnolia vine
schisandrins (russian)
schisandra chinensis fruit
g01bqc0879 ,
wuweizins (chinese)
gomisins
unii-g01bqc0879
gomisins (japanese)
wu-wei-zi
omija
(+)-schizandrin
schisandrine
SCHEMBL568558
CS-3663
schisandrin [usp-rs]
dibenzo(a,c)cycloocten-6-ol, 5,6,7,8-tetrahydro-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-, (6s,7s,12ar)-
schizandrol
7alpha-hydroxyschizandronol
schisandrin (schisandrol a) (constituent of northern schisandra) [dsc]
schisandrin [inci]
schizandrine
HY-N0691
mfcd00905761
wuweizichun-a
wuweizi alcohol-a
schisandrin, united states pharmacopeia (usp) reference standard
bdbm50485610
schisandrin (schisandrol a) (constituent of northern schisandra)
schisandrin (usp-rs)
schizandrin, europepharmacopoeia (ep) reference standard
schizandrin, >=98% (hplc)
AKOS032962032
(6s,7s,12ar)-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c][8]annulen-6-ol
Q27151398
(9s,10s)-schizandrin
(6s,7s)-1,2,3,10,11,12-hexamethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c][8]annulen-6-ol
HMS3885M06
CCG-269043
7432-28-2
schizandrin
schisandrin
HMS3344I14
schizandrol;schizandrol-a;wuweizi alcohol-a;wuweizichun-a
(9s)-3,4,5,14,15,16-hexamethoxy-9,10-dimethyltricyclo[10.4.0.02,7]hexadeca-1(16),2,4,6,12,14-hexaen-9-ol

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Renal proximal tubular epithelial cells are the main targets of toxic drugs such as cisplatin (CisPt), an alkylating agent indicated for the treatment of solid organ tumors."( Protective effects of schizandrin and schizandrin B towards cisplatin nephrotoxicity in vitro.
Antoine, MH; Bunel, V; Duez, P; Nortier, J; Stévigny, C, 2014
)
0.4

Pharmacokinetics

ExcerptReferenceRelevance
" This method was successfully applied for the pharmacokinetic studies in rats."( Determination of schizandrin in rat plasma by high-performance liquid chromatography-mass spectrometry and its application in rat pharmacokinetic studies.
Li, H; Li, X; Wang, G; Wang, R; Wang, W; Xie, H; Xu, M; Yue, L; Zhu, D, 2005
)
0.33
"5, 2, 3, 4, 6, 8, 10 and 12h) after administration, the concentrations of schizandrin in rat plasma were determined by LC-MS, and main pharmacokinetic parameters were estimated."( Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats.
Huang, Q; Jia, Y; Wang, G; Wang, W; Xie, H; Xu, M, 2008
)
0.35
" The terminate half-life (T(1/2)) in male rats was shorter than that in female rats."( Gender difference regarding schizandrin pharmacokinetics in rats.
Huang, Q; Jia, YW; Li, H; Lv, T; Wang, GJ; Wang, R; Xie, HT; Xu, MJ,
)
0.13
" Its pharmacokinetic process calculated with 3p97 software was fitted to a one-compartment model."( [Preparation of enteric nanoparticles of Schisandra total lignanoids and preliminary study on its pharmacokinetics].
Huang, X; Huang, YJ; Li, YB; Wang, Q; Xiao, XH; Yuan, HL, 2009
)
0.35
"To investigate the pharmacokinetic interaction among three major bioactive compounds of Shengmai formula."( [Pharmacokinetics interaction among three major active compounds of Shengmai formula in rats].
Fan, XH; Guo, WJ; Shao, Q; Zhang, YF, 2012
)
0.38
" The pharmacokinetic parameters of three compounds in single or combination form were calculated by WinNonLinu6."( [Pharmacokinetics interaction among three major active compounds of Shengmai formula in rats].
Fan, XH; Guo, WJ; Shao, Q; Zhang, YF, 2012
)
0.38
"Compared with single drug group, the peak concentration of ginsenoside Rg(1) in combined group increased from(0."( [Pharmacokinetics interaction among three major active compounds of Shengmai formula in rats].
Fan, XH; Guo, WJ; Shao, Q; Zhang, YF, 2012
)
0.38
"Combined oral administration of three compounds of Shengmai formula can improve the bioavailability of ginsenoside RgRg(1), however it does not change the pharmacokinetic behavior of ginsenoside RbRg(1) and schisandrin."( [Pharmacokinetics interaction among three major active compounds of Shengmai formula in rats].
Fan, XH; Guo, WJ; Shao, Q; Zhang, YF, 2012
)
0.38
"The concentration-time curve of Schisandra chinensis extract was described by a single compartment model, Cmax was (2."( [Pharmacokinetics and tissue distribution of Schisandra chinensis extract in mice].
Guan, J; Sun, DY; Zhang, XR; Zhao, Y; Zhu, HY, 2011
)
0.37
" In this work, plasma pharmacokinetic characteristics of lignans components after oral administration SMS were investigated using UPLC-Q-TOF/MS method."( Pharmacokinetic study of schisandrin, schisandrol B, schisantherin A, deoxyschisandrin, and schisandrin B in rat plasma after oral administration of Shengmaisan formula by UPLC-MS.
Han, Y; Sun, H; Wang, X; Wei, W; Wu, F; Zhang, A, 2013
)
0.39
" This paper was designed to study on the plasma pharmacokinetic for its absorption process, and to compare the pharmacokinetics of its active ingredients in normal and insomnic rats orally administrated with the prescription."( Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
Bi, K; Chen, X; Fan, R; Geng, L; He, B; Jia, Y; Li, Q; Su, D; Wei, B; Zhao, L, 2013
)
0.39
" It is valuable to investigate their pharmacokinetic and pharmacodynamic behavior and potential synergistic effect for better drug development and clinical application."( A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Cheng, Y; Fan, X; Guo, W; Li, Z; Shao, Q; Zhan, S, 2014
)
0.4
"Pharmacokinetic and nitric oxide (NO) release pharmacodynamic drug-drug interactions of ginsenoside Rg1, ginsenoside Rb1 and schisandrin were studied after intravenous administration of each compound with the dose of 10 mg/kg and their mixture with the total dose of 10 mg/kg to isoproterenol (ISO)-induced myocardial ischemia rats."( A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Cheng, Y; Fan, X; Guo, W; Li, Z; Shao, Q; Zhan, S, 2014
)
0.4
"The result obtained from this study suggested pharmacokinetic and pharmacodynamic drug-drug interactions between ginsenoside Rg1, Rb1 and schisandrin."( A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Cheng, Y; Fan, X; Guo, W; Li, Z; Shao, Q; Zhan, S, 2014
)
0.4
" The parameters area under the plasma concentration-time curve from time zero to the final measurable point and from time zero to infinity, and peak concentration were significantly increased, with a prolonged mean residence time and a corresponding decrease in clearance in comparision with the Schisandra-alone group."( Comparative pharmacokinetics and tissue distribution of schisandrin, deoxyschisandrin and schisandrin B in rats after combining acupuncture and herb medicine (schisandra chinensis).
Dai, G; Ji, D; Li, L; Lu, T; Mao, C; Sun, Y; Wu, X; Xu, B; Yin, F; Zhou, Y, 2014
)
0.4
" This method was successfully applied to the pharmacokinetic study of the five compounds in rats after oral administration of Shenqi Wuwei chewable tablets."( Simultaneous determination of calycosin-7-O-β-d-glucoside, calycosin, formononetin, astragaloside IV and schisandrin in rat plasma by LC-MS/MS: application to a pharmacokinetic study after oral administration of Shenqi Wuwei chewable tablets.
An, Y; Shi, G; Sun, X; Wu, Q; Wu, X; Zhang, M; Zhang, P, 2014
)
0.4
" In pharmacokinetic studies, rats were divided into four groups."( Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu, X; Liu, Y; Wang, Y; Zhang, D; Zhang, W, 2018
)
0.48
" The SD, ST, and SZ were selected as effective candidates to perform comparisons of liver targeting among the solution (SES), β-cyclodextrin inclusion compound (SCF-E-β-CD), liposome (SEL), and SCL of SCF-E to characterize the pharmacokinetic behaviors and liver targeting in rats."( Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract.
Chen, W; Ding, Z; Guo, Y; Hu, J; Jiang, Y; Xiao, J; Zhang, B; Zhang, Y, 2019
)
0.51
" However, pharmacokinetic data on the ingredients are essential in addition to data on their pharmacological activities to accurately determine the active ingredients in NYT."( Pharmacokinetic study of Ninjin'yoeito: Absorption and brain distribution of Ninjin'yoeito ingredients in mice.
Kaifuchi, N; Matsumoto, T; Sakamoto, T; Setou, M; Takahashi, Y; Takiyama, M; Watanabe, J, 2021
)
0.62

Compound-Compound Interactions

ExcerptReferenceRelevance
" After dynamic catalytic transformation by 201×7 resin combined with purification of HPD5000 resin, the yield and the purity of free biphenyl cyclooctene lignans in the product were 132."( Preparation of high purity biphenyl cyclooctene lignans from Schisandra extract by ion exchange resin catalytic transformation combined with macroporous resin separation.
Liu, TT; Ma, CH; Yang, FJ; Yang, L; Zhang, L; Zhang, ZH; Zhao, CJ; Zu, YG, 2011
)
0.37
"Pharmacokinetic and nitric oxide (NO) release pharmacodynamic drug-drug interactions of ginsenoside Rg1, ginsenoside Rb1 and schisandrin were studied after intravenous administration of each compound with the dose of 10 mg/kg and their mixture with the total dose of 10 mg/kg to isoproterenol (ISO)-induced myocardial ischemia rats."( A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Cheng, Y; Fan, X; Guo, W; Li, Z; Shao, Q; Zhan, S, 2014
)
0.4
"The result obtained from this study suggested pharmacokinetic and pharmacodynamic drug-drug interactions between ginsenoside Rg1, Rb1 and schisandrin."( A pharmacokinetic and pharmacodynamic study of drug-drug interaction between ginsenoside Rg1, ginsenoside Rb1 and schizandrin after intravenous administration to rats.
Cheng, Y; Fan, X; Guo, W; Li, Z; Shao, Q; Zhan, S, 2014
)
0.4
" Each group was orally treated with DSD alone (Group 1), DSD combined with EGCG (Group 2), SD alone (Group 3) and SD combined with EGCG (Group 4)."( Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu, X; Liu, Y; Wang, Y; Zhang, D; Zhang, W, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" These results indicate that some ingredients in SMS may increase the dissolution of schizandrin when decocting in vitro, and delay its elimination and enhance its bioavailability in rat."( Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats.
Huang, Q; Jia, Y; Wang, G; Wang, W; Xie, H; Xu, M, 2008
)
0.35
" An HPLC method was employed to determine the concentration of deoxyschisandrin (QS) and schisantherin A (SA) in plasma, which were used as an index of Schisandra total lignanoids, and the bioavailability of the nanoparticles was compared with the reference group by oral administration using SD rats."( [Preparation of enteric nanoparticles of Schisandra total lignanoids and preliminary study on its pharmacokinetics].
Huang, X; Huang, YJ; Li, YB; Wang, Q; Xiao, XH; Yuan, HL, 2009
)
0.35
" The main purpose of this work is to prepare self-emulsifying drug delivery systems (SEDDS) for enhancing the solubility, dissolution rate, and oral bioavailability of poorly water-soluble traditional Chinese medicines, Wurenchun."( Enhanced oral bioavailability of Wurenchun (Fructus Schisandrae Chinensis extracts) by self-emulsifying drug delivery systems.
Ji, H; Liu, H; Liu, Y; Shao, B; Tang, J; Wu, L; Zhu, D, 2010
)
0.36
"Combined oral administration of three compounds of Shengmai formula can improve the bioavailability of ginsenoside RgRg(1), however it does not change the pharmacokinetic behavior of ginsenoside RbRg(1) and schisandrin."( [Pharmacokinetics interaction among three major active compounds of Shengmai formula in rats].
Fan, XH; Guo, WJ; Shao, Q; Zhang, YF, 2012
)
0.38
" The main problem associated with the major bioactive lignans oral administration is low oral bioavailability due to the lignans' poor aqueous solubility and taste."( Pharmacokinetics and liver uptake of three Schisandra lignans in rats after oral administration of liposome encapsulating β-cyclodextrin inclusion compound of Schisandra extract.
Chen, W; Ding, Z; Guo, Y; Hu, J; Jiang, Y; Xiao, J; Zhang, B; Zhang, Y, 2019
)
0.51
" Moreover, this study also furnished a strategy for improving the oral bioavailability of different types of ginsenosides by drug combinations."( Effects of schisandra lignans on the absorption of protopanaxadiol-type ginsenosides mediated by P-glycoprotein and protopanaxatriol-type ginsenosides mediated by CYP3A4.
Hu, H; Li, Y; Wang, Z; Xu, C; Yang, K; You, Y; Zhao, L; Zhou, W, 2024
)
1.44

Dosage Studied

ExcerptRelevanceReference
"Rats were divided into 7 groups and dosed consecutively for 7 days with mono and combined-therapy administrations."( A metabonomic study of cardioprotection of ginsenosides, schizandrin, and ophiopogonin D against acute myocardial infarction in rats.
Jiang, M; Kang, L; Li, Z; Liu, X; Wang, Y; Xu, L; Zhao, X, 2014
)
0.4
" Kampo formulation containing SF is usually prepared as decoctions in the dosage form of whole crude drug (W), as its size is small enough to measure using a spoon."( Effects of crushed Schisandra Fruit on the content of lignans in Kampo decoction.
Atsumi, T; Makino, T; Ohtsuka, I; Yokogawa, T; Yokoyama, Y, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency3.98110.28189.721235.4813AID2326
importin subunit beta-1 isoform 1Homo sapiens (human)Potency2.90935.804836.130665.1308AID540253
snurportin-1Homo sapiens (human)Potency2.90935.804836.130665.1308AID540253
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency2.90935.804816.996225.9290AID540253
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency3.98110.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency3.98110.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency3.98110.15855.287912.5893AID540303
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (70)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID380430Cytotoxicity against human SKOV3 cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID475090Inhibition of 5-LOX-mediated LTB4 production from stimulated human neutrophile granulocytes at 50 uM after 10 mins by EIA2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.
AID721570Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay2013European journal of medicinal chemistry, Jan, Volume: 59Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity.
AID313795Antiproliferative activity against human SK-HEP1 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID1383310Antiproliferative activity against human DU145 cells after 48 hrs by MTT assay2018European journal of medicinal chemistry, Apr-10, Volume: 149Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
AID380432Inhibition of COX2 in mouse macrophages2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID721571Cytotoxicity against mouse LLC cells after 72 hrs by MTT assay2013European journal of medicinal chemistry, Jan, Volume: 59Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity.
AID569567Therapeutic index, ratio of CC50 for human C1866 cells to EC50 for HIV1-3B2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Compounds from Kadsura angustifolia with anti-HIV activity.
AID313800Antiproliferative activity against human A549 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID1129459Hepatoprotective activity against carbon tetrachloride-induced toxicity in human HL-7702 cells assessed as increase of cell survival rate at 0.2 ug/ul pretreated for 12 hrs before carbon tetrachloride addition by MTS assay relative to control2014Bioorganic & medicinal chemistry letters, Apr-01, Volume: 24, Issue:7
Synthesis and the hepatoprotective activity of dibenzocyclooctadiene lignan derivatives.
AID380429Cytotoxicity against human BT549 cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID380424Cytotoxicity against human HL60 cells by XTT assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1664610Cytotoxicity against human HEK293 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
AID380428Cytotoxicity against human KB cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID721566Toxicity in brine shrimp larvae assessed as mortality after 24 hrs by microtiter plate analysis2013European journal of medicinal chemistry, Jan, Volume: 59Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity.
AID379883Antiviral activity against HIV1 3B in H9 cells after 4 days by p24-antigen ELISA2006Journal of natural products, Dec, Volume: 69, Issue:12
Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora.
AID682028TP_TRANSPORTER: inhibition of DNR transport in HL60/ADR cells (overexpression of MRP1)2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID721569Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2013European journal of medicinal chemistry, Jan, Volume: 59Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity.
AID1371180Substrate activity at CYP3A5 (unknown origin) assessed as enzyme-mediated compound turnover assessed per pmol protein at 10 uM2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.
AID1371179Substrate activity at CYP3A4 (unknown origin) assessed as enzyme-mediated compound turnover assessed per pmol protein at 10 uM2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
A Naturally Occurring Isoform-Specific Probe for Highly Selective and Sensitive Detection of Human Cytochrome P450 3A5.
AID1664606Antiproliferative activity against human A549 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
AID313798Antiproliferative activity against human HCT15 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID379884Cytotoxicity against human H9 cells after 4 days2006Journal of natural products, Dec, Volume: 69, Issue:12
Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora.
AID678831TP_TRANSPORTER: inhibition of VCR transport in HL60/ADR cells (overexpression of MRP1)2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID313797Antiproliferative activity against human T47D cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID1383309Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay2018European journal of medicinal chemistry, Apr-10, Volume: 149Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
AID1383312Selectivity index, ratio of IC50 for HEK293 cells to IC50 for human DU145 cells2018European journal of medicinal chemistry, Apr-10, Volume: 149Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
AID313799Antiproliferative activity against human K562 cells after 72 hrs by MTT assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID313794Antiproliferative activity against human MDA-MB-231 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID678829TP_TRANSPORTER: inhibition of VP-16 transport in HL60/ADR cells (overexpression of MRP1)2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID475087Inhibition of ram seminal vesicle COX1 at 50 uM assessed as PGE2 concentration2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.
AID380431Antiinflammatory activity against LPS-induced prostaglandin E2 production in mouse macrophages upto 25 ug/ml2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1664609Antiproliferative activity against human HeLa cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
AID1664608Antiproliferative activity against human DU145 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
AID678830TP_TRANSPORTER: inhibition of VCR transport in HL60/MRP cells2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID1664607Antiproliferative activity against human RKOP3 cells assessed as reduction in cell viability measured after 48 hrs by MTT assay
AID475088Inhibition of ram seminal vesicle COX2 at 50 uM assessed as PGE2 level by EIA2010Bioorganic & medicinal chemistry, Apr-01, Volume: 18, Issue:7
Derivatives of schisandrin with increased inhibitory potential on prostaglandin E(2) and leukotriene B(4) formation in vitro.
AID380425Cytotoxicity against african green monkey Vero cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1383308Antiproliferative activity against human A549 cells after 48 hrs by MTT assay2018European journal of medicinal chemistry, Apr-10, Volume: 149Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
AID569566Antiviral activity against HIV1-3B infected in human C1866 cells assessed as inhibition of virus-induced cytopathic effect2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Compounds from Kadsura angustifolia with anti-HIV activity.
AID678828TP_TRANSPORTER: inhibition of VP-16 transport in HL60/MRP cells2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID313796Antiproliferative activity against human SNU638 cells after 72 hrs by SRB assay2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells.
AID380423Antioxidant activity in human HL60 cells assessed as inhibition of TPA-stimulated hydrogen peroxide induced DCFH-DA oxidation by fluorometric microplate assay2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID678832TP_TRANSPORTER: inhibition of DNR transport in HL60/MRP cells2007Life sciences, Jan-30, Volume: 80, Issue:8
Dibenzocyclooctadiene lignans: a class of novel inhibitors of multidrug resistance-associated protein 1.
AID1383307Antiproliferative activity against human HeLa cells after 48 hrs by MTT assay2018European journal of medicinal chemistry, Apr-10, Volume: 149Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
AID1168387Inhibition of P-gp-mediated doxorubicin efflux in human HL60/MDR cells assessed as intracellular doxorubicin accumulation at 25 uM preincubated for 15 mins measured after 60 mins by flow cytometry2014Journal of natural products, Oct-24, Volume: 77, Issue:10
Identification of key structural characteristics of Schisandra chinensis lignans involved in P-glycoprotein inhibition.
AID380427Cytotoxicity against human SK-MEL cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID721568Cytotoxicity against human U87 cells after 72 hrs by MTT assay2013European journal of medicinal chemistry, Jan, Volume: 59Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity.
AID779150Inhibition of Wnt/beta-catenin signaling pathway in human HEK293 cells at 20 uM after 24 hrs by dual luciferase reporter gene assay relative to vehicle-treated control2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells.
AID1383311Antiproliferative activity against HEK293 cells after 48 hrs by MTT assay2018European journal of medicinal chemistry, Apr-10, Volume: 149Synthesis and biological evaluation of Schizandrin derivatives as potential anti-cancer agents.
AID569565Cytotoxicity against human C1866 cells2011Bioorganic & medicinal chemistry letters, Feb-01, Volume: 21, Issue:3
Compounds from Kadsura angustifolia with anti-HIV activity.
AID721572Estrogenic activity in human MCF7 cells at 1 uM by luciferase reporter gene assay2013European journal of medicinal chemistry, Jan, Volume: 59Lignans from Schisandra sphenathera Rehd. et Wils. and semisynthetic schisantherin A analogues: absolute configuration, and their estrogenic and anti-proliferative activity.
AID380426Cytotoxicity against pig LLC-PK1 cells upto 48 uM2006Journal of natural products, Mar, Volume: 69, Issue:3
Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans.
AID1418398Inhibition of P-gp in human KBv200 cells assessed as potentiation of vincristine-induced cytotoxicity by measuring reduction in vincristine IC50 at 25 uM after 96 hrs by Western blot analysis relative to vincristine alone2018European journal of medicinal chemistry, Nov-05, Volume: 159Discovery of traditional Chinese medicine monomers and their synthetic intermediates, analogs or derivatives for battling P-gp-mediated multi-drug resistance.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (207)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (8.21)18.7374
1990's16 (7.73)18.2507
2000's40 (19.32)29.6817
2010's94 (45.41)24.3611
2020's40 (19.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Reviews8 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
Other184 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]